These results demonstrate that targeting module optimization of EVs shifts the CD19/EV endocytic pathway from CME to ADE in B‐ALL target cells, which is critical for EV‐mediated CD19 depletion and target cell killing. This evidence concerns the gene CD19 and acute lymphoblastic leukemia.